Innovating Works

H2020

Cerrada
HORIZON-MISS-2024-CANCER-...
HORIZON-MISS-2024-CANCER-01-01: Use cases for the UNCAN.eu research data platform
Expected Outcome:The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2].
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 18-09-2024.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Hace 2 mes(es) del cierre de la convocatoria y aún no tenemos información sobre los proyectos financiados, puede que esta información se publique pronto.
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

Expected Outcome:The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2].

 Proposal(s) under this topic are expected to contribute to all of the following outcomes:

The UNCAN.eu platform is developed by federating a network of cancer data nodes built on European and national computing infrastructures that link different cancer data holders across European countries.Use-cases focusing on the understanding of cancer initiation and progression are designed and implemented by multidisciplinary teams to develop tools and services for working with FAIR data.Researchers and clinicians use the electronic resources provided by the UNCAN.eu platform to access, manage and analyse data of heterogeneous types and belonging to different research domains at an unprecedented scale. Scope:The successful proposal should:

Develop the UNCAN.eu platform by integrating a... ver más

Expected Outcome:The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2].

 Proposal(s) under this topic are expected to contribute to all of the following outcomes:

The UNCAN.eu platform is developed by federating a network of cancer data nodes built on European and national computing infrastructures that link different cancer data holders across European countries.Use-cases focusing on the understanding of cancer initiation and progression are designed and implemented by multidisciplinary teams to develop tools and services for working with FAIR data.Researchers and clinicians use the electronic resources provided by the UNCAN.eu platform to access, manage and analyse data of heterogeneous types and belonging to different research domains at an unprecedented scale. Scope:The successful proposal should:

Develop the UNCAN.eu platform by integrating and, where relevant, complementing existing or planned data nodes of European research infrastructures and/or other national infrastructures that may link various cancer data holders across Member States and Associated Countries (e.g. hospitals, research centres, comprehensive cancer centres, etc.). The number of Member States involved should be sufficient to demonstrate scalability and flexibility of the UNCAN.eu platform while allowing for stepwise onboarding of more countries.Provide tools, services and workflows to researchers across data nodes for dataset creation, standardisation, data discovery, secure access, management, visualization, harmonization, analysis and other functions as appropriate. This task should capitalise on EOSC4cancer's achievements, integrating and expanding as appropriate the available tools and solutions. It should also take advantage of the European Health Data Space and the European Open Science Cloud frameworks.Design and implement a rich and diverse portfolio of use-cases to inform, steer the development and demonstrate the validity of the UNCAN.eu platform. Use cases should focus on research questions that are in line with the Cancer Mission objectives and that may advance the understanding of mechanisms involved in cancer development and progression beyond the current state of the art. At least one use-case should target a cancer type with a 5-year overall survival of less than 50% from the time of diagnosis. A second use-case should target paediatric cancer.At the same time, use-cases should be functional to the design and implementation of UNCAN.eu to increase the diversity of digital tools and services available for cancer researchers. The mobilisation and integration of a large amount of research and real word data beyond current practice and a balanced participation of clinicians, disease experts and data scientists will be essential to achieve the objectives of this topic. Due attention should be paid to sex and gender, disaggregating the data as appropriate.The successful consortium should develop innovative approaches, to integrate and analyse heterogeneous data from multiple sources and different research domains[3], including the participation of the necessary interdisciplinary set of European infrastructures and national data nodes. In this regard, at least one use-case should integrate imaging, digital pathology and genomic data, using and/or contributing with new data sources to the Genomics Data Infrastructure (GDI)[4] and Cancer Image Europe (EUCAIM)[5].Give emphasis to data being managed and shared in line with the FAIR principles, and the concept of FAIR-by-design is applied wherever possible. The applicants must demonstrate that the necessary data sources are, or will be, effectively and timely available. During the project lifetime, new data sources that might become available at a later stage can be accommodated as well as allowing additional data holders to join the UNCAN.eu platform. Results must be open source and made available through a public repository under a permissive license. Open access data should be provided whenever possible.Give due consideration to, and establish appropriate links with, EU-funded initiatives such as EHDS-related governance and implementation actions[6], the European Network of Cancer Registries[7].Foresee to establish links with the successful proposal resulting from the topic HORIZON-MISS-2024-CANCER-01-02 ‘Support dialogue towards the development of national cancer data nodes'. This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, to produce meaningful and significant effects enhancing the societal impact of the related research activities.

The Commission will facilitate coordination. Therefore, proposals should include a budget for networking, attendance at meetings, and potential joint activities without the prerequisite to give details of these at this stage. Examples are organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate.

Successful proposal will be asked to join the 'Understanding' cluster for the Mission on Cancer established in 2022[8]. The details of joint activities will be defined during the grant agreement preparation phase and during the life of the project.

[1] https://research-and-innovation.ec.europa.eu/system/files/2021-09/cancer_implementation_plan_for_publication_final_v2.pdf

[2] https://eosc4cancer.eu/

[3] Including – but not limiting to – genomics and other omics data, digital pathology, real world data, cancer registries, patient-derived cancer models, lifestyle, socio-economic, occupational and environmental data. In each use-case integration of clinical data from different sources is required.

[4] https://gdi.onemilliongenomes.eu/

[5] https://cancerimage.eu/

[6] https://ehds2pilot.eu/

[7] https://encr.eu/

[8] In order to address the objectives of the Mission on Cancer, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions.

ver menos

Temáticas Obligatorias del proyecto: Temática principal:
Healthcare Medical Research Digital Health Biophotonics Oncology Artificial Intelligence Data Management

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: *Presupuesto para cada participante en el proyecto
Requisitos técnicos: Expected Outcome:The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2]. Expected Outcome:The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2].
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.
Certificado DNSH: Los proyectos presentados a esta línea deben de certificarse para demostrar que no causan perjuicio al medio ambiente. + info

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
Deducción I+D+i:
0% 25% 50% 75% 100%
La empresa puede aplicar deducciones fiscales en I+D+i de los gastos del proyecto y reducir su impuesto de sociedades. + info